CD274 and lung adenocarcinoma: In this context, it was suggested that KYNU could be used as a potential prognostic factor in lung adenocarcinoma with activated NRF2, since it was correlated with Treg maturation, increased levels of PD-1 and PD-L1, immunosuppression and, consequently, poor overall survival [38].